ISPOR - HTA78 Evaluations of Cost-Utility Analyses of Pharmaceuticals Receiving Market Authorization Based on Single-Arm Trials in the Netherlands

Full Text

HTA78 Evaluations of Cost-Utility Analyses of Pharmaceuticals Receiving Market Authorization Based on Single-Arm Trials in the Netherlands

Abstract

Authors

R Efe S Vijgen

Back to Volume 25, Supplemental Issue 12S

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now